Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2375 (LINC02375) is a long intergenic non-coding RNA (lincRNA), which is a subtype of long non-coding RNA (lncRNA) transcribed from regions of the genome that do not overlap with protein-coding genes[1][3][7]. LincRNAs typically function in regulating gene expression through mechanisms such as chromatin remodeling, modulation of transcription, and acting as enhancers, but most individual lincRNAs—including LINC02375—remain poorly characterized at the functional level[1][3][7]. There is currently no evidence that LINC02375 acts as a classical therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), nor are there known drugs or disease associations specifically linked to this lincRNA[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2375 (LINC02375).